生物植入物市场－全球产业规模、份额、趋势、机会和预测，依产品类型、材料、最终用户、地区和竞争格局划分，2020-2030年预测

2024年全球生物植入物市场规模为1,322.4亿美元，预计2030年将以10.85%的复合年增长率成长至2,453.2亿美元。全球生物植入物市场正经历着由多种因素驱动的扩张。其中一个主要驱动因素是全球人口老化加剧，这与需要植入式解决方案的老年相关疾病发生率上升密切相关。同时，心血管疾病和肌肉骨骼疾病等慢性病的盛行率上升也显着推动了市场需求。此外，生物材料科学和外科技术的不断进步，包括3D列印和微创技术的创新，提高了植入物的有效性并拓展了其应用领域。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球生物植入物市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品类型（心血管植体、脊椎植入物、骨科植体、牙科植体、眼科植体、其他植体）
  • 依材料分类（生物材料、金属及合金、陶瓷、聚合物、其他材料）
  • 按最终使用者（医院和诊所、门诊手术中心、其他）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美生物植入物市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲生物植入物市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太生物植入物市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲生物植入物市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲生物植入物市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球生物植入物市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• BIOTRONIK SE & Co. KG
• Invibio Limited
• Wright Medical Group NV
• Edwards Lifesciences Corporation
• MiMeDX Group Inc.
• Stryker Corporation
• Endo International plc
• Smith & Nephew plc
• Zimmer Biomet Holdings Inc
• Ethicon Inc.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Bio-Implants Market , valued at USD 132.24 Billion in 2024, is projected to experience a CAGR of 10.85% to reach USD 245.32 Billion by 2030. The global bio-implants market is experiencing expansion driven by several factors. A primary driver is the increasing aging global population, which correlates with a higher incidence of age-related conditions requiring implantable solutions. Concurrently, the rising prevalence of chronic diseases, such as cardiovascular and musculoskeletal disorders, significantly contributes to demand. Furthermore, continuous advancements in biomaterial science and surgical technologies, including innovations in 3D printing and minimally invasive techniques, enhance implant efficacy and expand application areas.

Key Market Drivers

The global bio-implants market is significantly driven by the expanding global aging population demographics. As life expectancy increases worldwide, the prevalence of age-related degenerative conditions requiring implantable solutions rises, including orthopedic, cardiovascular, and neurological disorders. According to the UN Department of Economic and Social Affairs, in October 2024, the global population aged 60 years and over reached 1.2 billion people, necessitating a greater demand for advanced medical interventions to maintain quality of life.

Key Market Challenges

The elevated cost associated with bio-implant procedures and devices constitutes a significant impediment to market expansion. These high costs directly impact patient access, particularly in healthcare systems where individuals bear a substantial portion of treatment expenses or where insurance coverage is limited. This financial barrier can defer or prevent necessary implant procedures, thereby constraining the potential patient pool and limiting the overall market penetration for advanced bio-implants.

Key Market Trends

The expansion of 3D printing for patient-specific implants is transforming bio-implant manufacturing by enabling the creation of custom solutions tailored precisely to individual patient anatomy. This capability improves implant fit, reduces surgical complexities, and can enhance patient recovery outcomes. The ability to produce complex geometries with accuracy using additive manufacturing methods addresses the diverse needs arising from various medical conditions. For example, Materialise, a prominent additive manufacturing company, produced over 7,000 patient-specific implants and surgical guides in 2023, demonstrating the growing practical application of this technology in clinical settings. This trend supports personalized medicine by allowing for implants that integrate seamlessly with biological structures, thereby optimizing functionality and reducing potential complications.

Key Market Players

• BIOTRONIK SE & Co. KG
• Invibio Limited
• Wright Medical Group N.V.
• Edwards Lifesciences Corporation
• MiMeDX Group Inc.
• Stryker Corporation
• Endo International plc
• Smith & Nephew plc
• Zimmer Biomet Holdings Inc
• Ethicon Inc

Report Scope:

In this report, the Global Bio-Implants Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bio-Implants Market, By Product Type:

• Cardiovascular Implants
• Spinal Implants
• Orthopedic Implants
• Dental Implants
• Ophthalmic Implants
• Other Implants

Bio-Implants Market, By Material:

• Biomaterial Metal & Alloys
• Ceramics
• Polymers
• Other Materials

Bio-Implants Market, By End User:

• Hospitals & Clinics
• Ambulatory Surgical Centres
• Others

Bio-Implants Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Bio-Implants Market.

Available Customizations:

Global Bio-Implants Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bio-Implants Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Cardiovascular Implants, Spinal Implants, Orthopedic Implants, Dental Implants, Ophthalmic Implants, Other Implants)
  • 5.2.2. By Material (Biomaterial Metal & Alloys, Ceramics, Polymers, Other Materials)
  • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Surgical Centres, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Bio-Implants Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Material
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Bio-Implants Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Material
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Bio-Implants Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Material
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Bio-Implants Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Material
      • 6.3.3.2.3. By End User

7. Europe Bio-Implants Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Material
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Bio-Implants Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Material
      • 7.3.1.2.3. By End User
  • 7.3.2. France Bio-Implants Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Material
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Bio-Implants Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Material
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Bio-Implants Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Material
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Bio-Implants Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Material
      • 7.3.5.2.3. By End User

8. Asia Pacific Bio-Implants Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Material
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Bio-Implants Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Material
      • 8.3.1.2.3. By End User
  • 8.3.2. India Bio-Implants Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Material
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Bio-Implants Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Material
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Bio-Implants Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Material
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Bio-Implants Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Material
      • 8.3.5.2.3. By End User

9. Middle East & Africa Bio-Implants Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Material
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Bio-Implants Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Material
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Bio-Implants Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Material
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Bio-Implants Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Material
      • 9.3.3.2.3. By End User

10. South America Bio-Implants Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Material
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Bio-Implants Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Material
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Bio-Implants Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Material
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Bio-Implants Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Material
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Bio-Implants Market : SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. BIOTRONIK SE & Co. KG
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Invibio Limited
• 15.3. Wright Medical Group N.V.
• 15.4. Edwards Lifesciences Corporation
• 15.5. MiMeDX Group Inc.
• 15.6. Stryker Corporation
• 15.7. Endo International plc
• 15.8. Smith & Nephew plc
• 15.9. Zimmer Biomet Holdings Inc
• 15.10. Ethicon Inc.

16. Strategic Recommendations

17. About Us & Disclaimer